Previous Next

2024-04-02

Metabolites of the tricarboxylic acid pathway in the progression of chronic renal failure

Urology-nephrology

In this study, researchers evaluated the association between metabolites of the tricarboxylic acid pathway and the risk of progression to chronic kidney disease in patients with type 2 diabetes. Urinary lactate, pyruvate, citrate, alpha-ketoglutarate, succinate, fumarate and malate were measured by mass spectrometry. Over a median follow-up of 9.2 years, urinary lactate, fumarate and malate were associated with an increased risk of kidney damage, while citrate was associated with a low risk of kidney problems, after adjusting for cardio-renal risk factors. 


Source(s) :
Jian-Jun Liu et al. Urine tricarboxylic acid cycle metabolites and risk of end stage kidney disease in patients with type 2 diabetes. J Clin Endocrinol Metab. 2024 Mar 28:dgae199. ;

Last press reviews


Training to save lives

By Ana Espino | Published on August 26, 2025 | 2 min read

When a father’s anxiety leaves a mark

By Ana Espino | Published on August 25, 2025 | 3 min read

Single-cell epigenomic rewiring in alzheimer’s disease progression and cognitive resilience

By Lila Rouland | Published on August 21, 2025 | 2 min read